{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:48:11Z","timestamp":1790034491022,"version":"4.0.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Coronavirus disease 2019 (COVID-19)-related disruptions in healthcare services and clinical outcomes have been predicted and documented. However, little is known about how antiretroviral therapy (ART) adherence disruptions caused by the COVID-19 pandemic have manifested amidst the \u2018Undetectable = Untransmittable' campaign initiative. Using a patient's viral load as a proxy for medication adherence, our study aimed to determine the adherence to ART on first-line medications among adult people living with human immunodeficiency virus (PLWHIV) at the University Teaching Hospital in Lusaka, Zambia during the pandemic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a hospital-based cross-sectional study. Secondary data of PLWHIV registered to receive ART from the Adult Infectious Disease Centre was extracted from the SmartCare<jats:sup>\u00ae<\/jats:sup> electronic health record system to constitute a resultant data set that this study used. The data extraction form was used to extract values of dependent (ART adherence measured by viral load detectability) and independent variables and imported them into the statistical analysis tool, STATA version 16.1 MP. Descriptive statistics of individual characteristics, testing for associations using Pearson's chi-square test, and stratified and combined multivariable logistic regression were performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 7,281 adult PLWHIV included in this study, 9.0% (95% CI 8.3\u20139.6%) were virally detectable. Estimates of the odds ratios of detectable viral load remained significantly higher among adult PLWHIV who were initiated on ART after the U=U campaign was launched in Zambia and were on a monthly 2.51 (1.31\u20139.03) or 6-monthly 4.75 (3.52\u20136.41) dispensing of a dolutegravir-based regimen and those on 6-monthly dispensing of an efavirenz-based regimen 4.67 (2.16\u201310.08) compared to their counterparts. Overall estimates showed us the same picture 4.14 (3.22\u20135.31), having adjusted for all other predictor variables.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We found that a high proportion of people with detectable viral load in the study population, irrespective of medication refill interval and type of regimen, was concentrated among adult PLWHIV who started treatment during the COVID-19 epidemic waves, as compared to those who started treatment before the pandemic. This observed disparity suggests the inherent impact of the pandemic on the adherence to ART among adult PLWHIV in Lusaka, Zambia. This further illustrates how exposed program responses are to external shocks, especially in already weakened health systems, and the need to create program response buffers and resilient program-specific strategies to minimize the effect of external disruptions.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1094214","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T05:16:05Z","timestamp":1678684565000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Poor adherence to antiretroviral therapy among adult people living with HIV initiated during the COVID-19 epidemic waves \u2013 observations at the University Teaching Hospital in Lusaka, Zambia"],"prefix":"10.3389","volume":"11","author":[{"given":"Powell","family":"Kafwanka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Muyinza","family":"Nalule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Michelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"key":"B1","unstructured":"2021"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.3390\/ijerph18052564","article-title":"The trend of HIV\/AIDS incidence and risks associated with age, period, and birth cohort in four central african countries","volume":"18","author":"Martial","year":"2021","journal-title":"Int J Environ Res Public Health."},{"key":"B3","unstructured":"2021"},{"key":"B4","unstructured":"2021"},{"key":"B5","doi-asserted-by":"publisher","first-page":"ofaa529","DOI":"10.1093\/ofid\/ofaa529","article-title":"Evaluating HIV viral rebound among persons on suppressive antiretroviral treatment in the era of undetectable equals un transmittable","volume":"7","author":"Min","year":"2020","journal-title":"Open Forum Inf Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0272405","DOI":"10.1371\/journal.pone.0272405","article-title":"Achieving the 95 95 95 targets for all: a pathway to ending AIDS","volume":"17","author":"Frescura","year":"2022","journal-title":"PLoS One."},{"key":"B7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1001\/jama.2018.21167","article-title":"Viral load and transmissibility of hiv infection: undetectable equals un transmittable","volume":"321","author":"Eisinger","year":"2019","journal-title":"JAMA."},{"key":"B8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/sextrans-2020-054551","article-title":"Undetectable equals un transmittable (u = u): awareness and associations with health outcomes among people living with HIV in 25 countries","volume":"97","author":"Okoli","year":"2021","journal-title":"Sex Transm Infect."},{"key":"B9","unstructured":"Zambia Demographic and Health Survey 2018.2021"},{"key":"B10","unstructured":"WHO, Regional Office for Africa2021"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.15585\/mmwr.mm6931a4","article-title":"Increase in antiretroviral therapy enrollment among persons with HIV infection during the Lusaka HIV treatment surge \u2014 Lusaka Province, Zambia, January 2018\u2013June 2019","volume":"69","author":"Boyd","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ijid.2020.09.1480","article-title":"First COVID-19 case in Zambia \u2014 comparative phylogenomic analyses of SARS-CoV-2 detected in African countries","volume":"102","author":"Simulundu","year":"2021","journal-title":"Int J Inf Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3760\/cma.j.cn112338-20200314-00345","article-title":"Quick community survey on the impact of COVID-19 outbreak for the healthcare of people living with HIV","volume":"41","author":"Guo","year":"2020","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi."},{"key":"B15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5001\/omj.2011.38","article-title":"Patient medication adherence: measures in daily practice","volume":"26","author":"Jimmy","year":"2011","journal-title":"Oman Med J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4103\/1947-2714.109196","article-title":"Adherence to antiretroviral therapy among people living with HIV","volume":"5","author":"Achappa","year":"2013","journal-title":"N Am J Med Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/QAI.0000000000001019","article-title":"HIV Transmission risk persists during the first 6 months of antiretroviral therapy","volume":"72","author":"Mujugira","year":"2016","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-021-00400-9","article-title":"Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala","volume":"18","author":"Ort\u00edz","year":"2021","journal-title":"AIDS Res Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"23259582221096520","DOI":"10.1177\/23259582221096522","article-title":"Evaluating barriers to viral suppression among people with HIV in Santiago, Dominican Republic","volume":"21","author":"McCarthy","year":"2022","journal-title":"J Int Assoc Provid AIDS Care."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e25543","DOI":"10.1002\/jia2.25543","article-title":"High levels of viral load monitoring and viral suppression under treat all in Rwanda \u2013 a cross-sectional study","volume":"23","author":"Ross","year":"2020","journal-title":"J Int AIDS Soc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/QAI.0000000000002811","article-title":"Impact of the COVID-19 pandemic on use of HIV care, antiretroviral therapy adherence, and viral suppression: an observational cohort study from Uganda","volume":"88","author":"Wagner","year":"2021","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e007312","DOI":"10.1136\/bmjgh-2021-007312","article-title":"Mitigating the effects of COVID-19 on HIV treatment and care in Lusaka, Zambia: a before\u2013after cohort study using mixed effects regression","volume":"7","author":"Pry","year":"2022","journal-title":"BMJ Global Health."},{"key":"B23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12889-021-10296-9","article-title":"Consequences of COVID-19 crisis for persons with HIV: the impact of social determinants of health","volume":"21","author":"Waterfield","year":"2021","journal-title":"BMC Public Health."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1007\/s10461-022-03630-8","article-title":"Impacts of the COVID-19 pandemic on people living with hiv who are members of vulnerable groups in Vietnam","volume":"26","author":"Tran","year":"2022","journal-title":"AIDS Behav."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0270855","DOI":"10.1371\/journal.pone.0270855","article-title":"Factors associated with HIV viral suppression among adolescents in Kabale district, South Western Uganda","volume":"17","author":"Gordon","year":"2022","journal-title":"PLoS ONE."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.2147\/HIV.S345731","article-title":"Factors associated with viral suppression among adolescents on antiretroviral therapy in Homa Bay County, Kenya: a retrospective cross-sectional study","volume":"13","author":"Mwangi","year":"2021","journal-title":"HIV."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e9247451","DOI":"10.1155\/2020\/9247451","article-title":"Viral suppression and its associated factors in HIV patients on highly active antiretroviral therapy (HAART): a retrospective study in the ho municipality, Ghana","volume":"2020","author":"Lokpo","year":"2020","journal-title":"AIDS Res Treat."},{"key":"B28","doi-asserted-by":"publisher","first-page":"838234","DOI":"10.3389\/fviro.2022.838234","article-title":"Predictors and timing to viral suppression in HIV-infected pregnant women in the university of Zimbabwe birth cohort study during the era of lifelong antiretroviral therapy (Option B+ Treatment Strategy)","volume":"2","author":"Duri","year":"2022","journal-title":"Front Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"21650","DOI":"10.7448\/IAS.20.5.21650","article-title":"Multi-month prescriptions, fast-track refills, and community ART groups: results from a process evaluation in Malawi on using differentiated models of care to achieve national HIV treatment goals","volume":"20","author":"Prust","year":"2017","journal-title":"J Int AIDS Soc."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1186\/s12889-018-5961-0","article-title":"Outcomes of community-based differentiated models of multi-month dispensing of antiretroviral medication among stable HIV-infected patients in Lesotho: a cluster randomised non-inferiority trial protocol","volume":"18","author":"Faturiyele","year":"2018","journal-title":"BMC Public Health."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e628","DOI":"10.1016\/S2214-109X(21)00039-5","article-title":"Multimonth dispensing of up to 6 months of antiretroviral therapy in Malawi and Zambia (INTERVAL): a cluster-randomised, non-blinded, non-inferiority trial","volume":"9","author":"Hoffman","year":"2021","journal-title":"Lancet Global Health."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e629","DOI":"10.1016\/S2352-3018(20)30211-3","article-title":"Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models","volume":"7","author":"Jewell","year":"2020","journal-title":"Lancet HIV."},{"key":"B33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12913-021-06176-y","article-title":"Impact of COVID-19 on health services utilization in Province-2 of Nepal: a qualitative study among community members and stakeholders","volume":"21","author":"Singh","year":"2021","journal-title":"BMC Health Serv Res."},{"key":"B34","volume-title":"Barriers to Accessing Medical Care in Sub-Saharan Africa in Early Stages of COVID-19 Pandemic","author":"Swindle","year":"2021"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0000843","DOI":"10.1371\/journal.pgph.0000843","article-title":"Effect of the COVID-19 pandemic on health service utilization across regions of Ethiopia: an interrupted time series analysis of health information system data from 2019\u20132020","volume":"2","author":"Mebratie","year":"2022","journal-title":"PLoS Global Public Health."},{"key":"B36","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1186\/s12913-021-06730-8","article-title":"Trends of follow-up clinic visits and admissions three-months before and during COVID-19 pandemic at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia: an interrupted time series analysis","volume":"21","author":"Abebe","year":"2021","journal-title":"BMC Health Serv Res."},{"key":"B37","doi-asserted-by":"crossref","unstructured":"ChipimoPJ\n          33090982First 100 Persons with COVID-19 \u2014 Zambia, March 18\u2013April 28, 2020. MMWR Morb Mortal Wkly Rep.2022","DOI":"10.15585\/mmwr.mm6942a5"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e25587","DOI":"10.1002\/jia2.25587","article-title":"PEPFAR's response to the convergence of the HIV and COVID-19 pandemics in Sub-Saharan Africa","volume":"23","author":"Golin","year":"2020","journal-title":"J Int AIDS Soc."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1094214\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T05:16:24Z","timestamp":1678684584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1094214\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":38,"alternative-id":["10.3389\/fpubh.2023.1094214"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1094214","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"article-number":"1094214"}}